Celestra Inc.

352770 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩5,250.00
+0.00%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of -3.96.
  • Return on equity is healthy at 189.1%.
  • Return on capital employed is healthy at 139.6%.

!Watch-points

  • Thin interest cover: operating profit covers interest only about -0.8 times.
  • The company reported a net loss in the latest period.
  • Current ratio of 0.22 is below 1, so current liabilities exceed current assets.
  • Sales growth has been slow over five years (about -27% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
-11.06

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
2 / 5

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 5 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩134억
Current Price₩ 5,250.00
High / Low₩ 5,247.38 / 350.00
Stock P/E-1.14
Book Value₩ -2,437.26
ROCE139.55%
ROE189.14%
Debt to Equity-3.96
Current Ratio0.22
EPS₩ -4,610.00
PAT Margin-586.29%
ICR-0.75
Compounded Sales Growth
10 Years
5 Years -27.20%
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year 189.14%
Educational data only. Not a recommendation to buy, sell or hold any security.